POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
| Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
| BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
| JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
| PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
| Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
| Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
| Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |
| Avidity Partners Management LP | 2,411,600 | $17,532,332 | 0.58% |
| Rubric Capital Management LP | 2,645,336 | $19,231,593 | 0.50% |
| Affinity Asset Advisors, LLC | 149,586 | $1,087,490 | 0.36% |
| Nantahala Capital Management | 572,191 | $4,159,829 | 0.32% |
| Onex Canada Asset Management Inc. | 772,905 | $5,619,019 | 0.31% |
| Delphia (USA) Inc. | 28,905 | $210,139 | 0.26% |
| SECTORAL ASSET MANAGEMENT INC | 182,668 | $1,327,996 | 0.26% |
| Ikarian Capital, LLC | 139,565 | $1,014,639 | 0.23% |
| Corton Capital Inc. | 35,665 | $259,285 | 0.18% |
| FIRETHORN WEALTH PARTNERS, LLC | 27,380 | $207,267 | 0.16% |
External links
This page lists POINT BIOPHARMA GLOBAL INC's shareholders in Q1 2023. To view POINT BIOPHARMA GLOBAL INC's shareholder history, click here.